These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15012776)
1. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy. Anzola M; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo M; Burgos JJ J Gastroenterol Hepatol; 2004 Apr; 19(4):397-405. PubMed ID: 15012776 [TBL] [Abstract][Full Text] [Related]
2. P14ARF gene alterations in human hepatocellular carcinoma. Anzola M; Cuevas N; López-Martínez M; Saiz A; Burgos JJ; Martínez de Pancorboa M Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):19-26. PubMed ID: 15095848 [TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
4. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830 [TBL] [Abstract][Full Text] [Related]
5. p16 is a major inactivation target in hepatocellular carcinoma. Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001 [TBL] [Abstract][Full Text] [Related]
6. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762 [TBL] [Abstract][Full Text] [Related]
8. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter]. Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629 [TBL] [Abstract][Full Text] [Related]
9. Frequent allelic loss on chromosome 9 in hepatocellular carcinoma. Liew CT; Li HM; Lo KW; Leow CK; Lau WY; Hin LY; Lim BK; Lai PB; Chan JY; Wang XQ; Wu S; Lee JC Int J Cancer; 1999 May; 81(3):319-24. PubMed ID: 10209942 [TBL] [Abstract][Full Text] [Related]
10. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Xing EP; Nie Y; Wang LD; Yang GY; Yang CS Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853 [TBL] [Abstract][Full Text] [Related]
13. Two distinct pathways of p16 gene inactivation in gallbladder cancer. Tadokoro H; Shigihara T; Ikeda T; Takase M; Suyama M World J Gastroenterol; 2007 Dec; 13(47):6396-403. PubMed ID: 18081229 [TBL] [Abstract][Full Text] [Related]
14. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963 [TBL] [Abstract][Full Text] [Related]
15. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma. Chu HJ; Heo J; Seo SB; Kim GH; Kang DH; Song GA; Cho M; Yang US J Korean Med Sci; 2004 Feb; 19(1):83-6. PubMed ID: 14966347 [TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936 [TBL] [Abstract][Full Text] [Related]
17. Infrequent alterations of the p16INK4A gene in liver cancer. Kita R; Nishida N; Fukuda Y; Azechi H; Matsuoka Y; Komeda T; Sando T; Nakao K; Ishizaki K Int J Cancer; 1996 Jul; 67(2):176-80. PubMed ID: 8760583 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774 [TBL] [Abstract][Full Text] [Related]
19. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma. Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146 [TBL] [Abstract][Full Text] [Related]
20. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma. Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]